Macrophage oxidative modification of low density lipoprotein occurs independently of its binding to the low density lipoprotein receptor

Journal of Lipid Research

Volumn 37, Issue 4, 1996, Pages 835-843

  Tangirala, Rajendra K ^a   Mol, Marc J T ^a,b   Steinberg, Daniel ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

apoB E receptor; atherosclerosis; LDL receptor deficient macrophages; LDL receptor knockout mice; lipid peroxides; lipoprotein oxidation; modified lipoproteins; resident peritoneal macrophages

Indexed keywords

LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; LIPID ANALYSIS; LIPID METABOLISM; LIPID OXIDATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; RECEPTOR BINDING;

ANIMALS; CHOLESTEROL; KINETICS; LIPOPROTEINS, LDL; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; OXIDATION-REDUCTION; RECEPTORS, LDL;

EID: 0030001626     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Steinberg, D., S. Parthasarathy, T. E. Carew, J. C. Khoo, and J. L. Witztum. 1989. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenecity. N. Engl. J. Med. 320: 915-924.
2. Witztum, J. L., and D. Steinberg. 1991. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88: 1785-1792.
3. Heinecke, J. W., L. Baker, H. Rosen, and A. Chait. 1986. Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. J. Clin. Invest. 77: 757-761.
4. Steinbrecher, U. P. 1988. Role of superoxide in endothelial-cell modification of low density lipoproteins. Biochim. Biophys. Acta. 959: 20-30.
5. Cathcart, M. K., A. K. McNally, D. W. Morel, and G. M. Chisolm. 1989. Superoxide anion participation in human monocyte-mediated oxidation of low density lipoprotein to a cytotoxin. J. Immunol. 142: 1963-1969.
6. Parthasarathy, S., E. Wieland, and D. Steinberg. 1987. Role of endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. Proc. Natl. Acad. Sci. USA. 86: 1046-1050.
7. McNally, A. K., G. M. Chilsolm III, D. W. Morel, and M. K. Cathcart. 1990. Activated human monocytes oxidize low density lipoprotein by a lipoxygenase-dependent pathway. J. Immunol. 145: 254-259.
8. Rankin, S. M., S. Parthasarathy, and D. Steinberg. 1991. Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages. J. Lipid Res. 32: 449-456.
9. Daugherty, A., J. I. Dunn, R. L. Rateri, and J. W. Heinecki. 1994. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94: 437-444.
10. Sparrow, C. P., and J. Olszewski. 1993. Cellular oxidation of low density lipoprotein is caused by thiol production in media containing transition metal ions. J. Lipid Res. 34: 1219-1228.
11. Fong, L. G., T. S. E. Albert, and S. E. Hom. 1994. Inhibition of the macrophage-induced oxidation of low density lipoprotein by interferon-γ. J. Lipid Res. 35: 893-904.
12. Maziere, C., M. Auclair, M-F. Ronveaux, S. Salmon, R. Santus, and J-C. Maziere. 1991. Estrogens inhibit copper and cell-mediated modification of low density lipoprotein. Atherosclerosis. 89: 175-182.
13. Breugnot, C., C. Maziere, M. Auclair, L. Mora, M. F. Ronveaux, S. Salmon, R. Santus, P. Morliere, A. Lenaers, and J-C. Maziere. 1991. Calcium antagonists prevent monocyte and endothelial cell-induced modification of low density lipoproteins. Free Rad. Res. Commun. 15: 91-100.
14. Maziere, C., M. Auclair, and J-C. Maziere. 1992. Lipophilic β-blockers inhibit monocyte and endothelial cell-mediated modification of low density lipoproteins. Biochim. Biophys. Acta. 1126: 314-318.
15. Aviram, M., and M. Rosenblat. 1994. Macrophage-mediated oxidation of extracellular low density lipoprotein requires an initial binding of the lipoprotein to its receptor. J. Lipid Res. 35: 385-398.
16. Cathcart, M. K., Q. Li, and G. M. Chisolm III. 1995. Lipoprotein receptor interactions are not required for monocyte oxidation of LDL. J. Lipid Res. 36: 1857-1865.
17. Ishibashi, S., M. S. Brown, J. L. Goldstein, R. D. Gerard, R. E. Hammer, and J. Hertz. 1993. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92: 883-893.
18. Ishibashi, S., J. L. Goldstein, M. S. Brown, J. Hertz, and D. K. Burns. 1994. Massive xanthomas and atherosclerosis in cholesterol-fed LDL receptor-negative mice. J. Clin. Invest. 93: 1885-1893.
19. Palinski, W., R. K. Tangirala, E. Miller, S. G. Young, and J. L. Witztum. 1995. Increased autoantibody titers against epitopes of oxidized low density lipoprotein in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 15: 1569-1576.
20. Havel, R. J., H. A. Eder, and J. H. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353.
21. Salacinski, P. R. P., C. McLean, J. E. C. Sykes, V. V. Clement-Jones, and P. J. Lowry. 1981. Iodination of proteins, glycoproteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1, 3, 4, 6-tetrachloro-3α, 6α-diphenyl glycoluril (Iodogen). Anal. Biochem. 117: 136-146.
22. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
23. Conti, M., P. C. Morand, P. Levillain, and A. Lemonnier. 1991. Improved fluorimetric determination of malonaldehyde. Clin. Chem. 37: 1273-1275.
24. Folch, J., J. M. Lees, and G. H. Sloane Stanley. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226: 497-509.
25. Reaven, P., S. Parthasarathy, B. Grasse, E. Miller, D. Steinberg, and J. L. Witztum. 1993. Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects. J. Clin. Invest. 91: 668-676.
26. Basu, S. K., J. L. Goldstein, R. G. W. Anderson, and M. S. Brown. 1976. Degradation of canonized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemic fibroblasts. Proc. Natl. Acad. Sci. USA. 73: 3178-3182.
27. Goldstein, J. L., S. K. Basu, and M. S. Brown. 1983. Receptor-mediated endocytosis of low-density lipoprotein in cultures cells. Methods Enzymol. 98: 241-260.
28. Sparrow, C. P., S. Parthasarathy, and D. Steinberg. 1989. A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. J. Biol. Chem. 264: 2599-2604.
29. Parthasarathy, S., D. J. Printz, D. Boyd, L. Joy, and D. Steinberg. 1986. Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis. 6: 505-510.
30. Leake, D. S., and S. M. Rankin. 1990. The oxidative modification of low density lipoprotein by macrophages. Biochem. J. 270: 741-748.
31. Henriksen, T., E. M. Mahoney, and D. Steinberg. 1981. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc. Natl. Acad. Sci. USA. 78: 6499-6503.
32. Rosenfeld, M. E., J. C. Khoo, E. Miller, S. Parthasarathy, W. Palinski, and J. L. Witztum. 1991. Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts. J. Clin. Invest. 87: 90-99.
33. Parthasarathy, S., L. G. Fong, M. T. Quinn, and D. Steinberg. 1990. Oxidative modification of LDL: comparison between cell-mediated and copper-mediated modification. Eur. Heart J. 11(Suppl. E): 83-87.
34. Goldstein, J. L., Y. K. Ho, S. K. Basu, and M. S. Brown. 1979. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA. 76: 333-337.
35. Brown, M. S., and J. L. Goldstein. 1983. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 52: 223-261.
36. Ishii, K., T. Kita, N. Kume, Y. Nagano, and C. Kawai. 1988. Uptake of acetylated LDL by peritoneal macrophages from normal and Watanabe heritable hyperlipidemic rabbits, an animal model for familial hypercholesterolemia. Biochim. Biophys. Acta. 962: 387-389.
37. Phillips, M. C., W. J. Johnson, and G. H. Rothblat. 1987. Mechanisms and consequences of cellular cholesterol exchange and transfer. Biochim. Biophys. Acta. 906: 223-276.
38. Johnson, W. J., F. H. Mahlberg, G. H. Rothblat, and M. C. Phillips. 1991. Cholesterol transport between cells and high-density lipoproteins. Biochim. Biophys. Acta. 1085: 273-298.
39. Rosenfeld, M. E., W. Palinski, S. Yla-Herttuala, S. Butler, and J. L. Witztum. 1990. Distribution of oxidation-specific lipid-protein adducts and apolipoprotein-B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis. 10: 336-349.